Syros Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SYRS Nasdaq 2836 www.syros.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals Inc (SYRS) Q2 2024 Earnings Call Highlights: Strategic Focus on ... - Oct 9th, 2024 7:33 pm
Insider Spends US$161k Buying More Shares In Syros Pharmaceuticals - Sep 14th, 2024 1:26 pm
Insider Buying: CFO Jason Haas Acquires 100,000 Shares of Syros Pharmaceuticals Inc (SYRS) - Sep 12th, 2024 11:00 pm
Insider Buying: President & CEO Conley Chee Acquires Shares of Syros Pharmaceuticals Inc (SYRS) - Sep 12th, 2024 11:00 pm
Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Aug 27th, 2024 11:00 am
Syros (SYRS) Falls 62% on Phase II Leukemia Study Termination - Aug 14th, 2024 2:19 pm
Syros Pharmaceuticals (SYRS) Loses -70.55% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Aug 14th, 2024 1:35 pm
Top Midday Decliners - Aug 13th, 2024 6:28 pm
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome - Aug 13th, 2024 1:41 pm
Syros’ stock craters after Phase II AML trial termination due to inefficacy - Aug 13th, 2024 1:13 pm
Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial - Aug 12th, 2024 8:15 pm
Does Syros Pharmaceuticals (SYRS) Have the Potential to Rally 251.92% as Wall Street Analysts Expect? - Aug 5th, 2024 1:55 pm
Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update - Jul 31st, 2024 11:30 am
Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024 - Jul 24th, 2024 11:00 am
Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why - Jul 17th, 2024 3:24 pm
Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week - Jun 17th, 2024 11:34 am
Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression - Jun 13th, 2024 11:00 am
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... - May 15th, 2024 7:03 am
Q1 2024 Syros Pharmaceuticals Inc Earnings Call - May 15th, 2024 5:14 am
Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update - May 14th, 2024 11:30 am